- Home
- WTBA vs ACIU Comparison
WTBA vs ACIU Comparison
Compare WTBA & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTBA
- ACIU
- Stock Information
- Founded
- WTBA 1893
- ACIU 2003
- Country
- WTBA United States
- ACIU Switzerland
- Employees
- WTBA N/A
- ACIU N/A
- Industry
- WTBA Major Banks
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- WTBA Finance
- ACIU Health Care
- Exchange
- WTBA Nasdaq
- ACIU Nasdaq
- Market Cap
- WTBA 301.1M
- ACIU 332.4M
- IPO Year
- WTBA N/A
- ACIU 2016
- Fundamental
- Price
- WTBA $23.94
- ACIU $3.12
- Analyst Decision
- WTBA Hold
- ACIU Strong Buy
- Analyst Count
- WTBA 1
- ACIU 2
- Target Price
- WTBA $23.00
- ACIU $12.00
- AVG Volume (30 Days)
- WTBA 22.4K
- ACIU 146.5K
- Earning Date
- WTBA 01-23-2025
- ACIU 11-05-2024
- Dividend Yield
- WTBA 4.23%
- ACIU N/A
- EPS Growth
- WTBA N/A
- ACIU N/A
- EPS
- WTBA 1.27
- ACIU N/A
- Revenue
- WTBA $77,394,000.00
- ACIU $48,505,404.00
- Revenue This Year
- WTBA N/A
- ACIU $85.33
- Revenue Next Year
- WTBA $13.99
- ACIU $80.69
- P/E Ratio
- WTBA $18.62
- ACIU N/A
- Revenue Growth
- WTBA N/A
- ACIU 4097200.00
- 52 Week Low
- WTBA $15.80
- ACIU $2.25
- 52 Week High
- WTBA $24.85
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- WTBA 58.58
- ACIU 44.22
- Support Level
- WTBA $23.06
- ACIU $3.10
- Resistance Level
- WTBA $23.95
- ACIU $3.21
- Average True Range (ATR)
- WTBA 0.53
- ACIU 0.12
- MACD
- WTBA -0.16
- ACIU -0.02
- Stochastic Oscillator
- WTBA 49.16
- ACIU 15.09
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.